Top View
- GLASS Methodology for Surveillance of National Antimicrobial Consumption
- Treatment-Drugs
- Prior Authorization — Select
- Olysio) Reference Number: CP.PHAR.280 Effective Date: 09.16 Last Review Date: 02.20 Line of Business: Medicaid Revision Log
- Updates in Hepatitis C Treatment
- Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir (Viekira XR, Viekira Pak) Reference Number: PA.CP.PHAR.278 Effective Date: 01/18 Last Review Date: 09/17 Revision Log
- Viekirax-INN-Ombitasvir, Paritaprevir, Ritonavir;
- NYSDOH Uninsured Care Programs Covered Services and ADAP
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Clinical Policy: Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir (Viekira Pak)
- Ribavirin Dose Management in HCV Patients Receiving Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin J
- Ombitasvir, Paritaprevir/Ritonavir Plus Dasabuvir Restricted To
- Treatment of HCV Genotype 4
- Viekira Pak-RBV and Psychiatric Changes CONFIDENTIAL
- (PDF) Download
- List of Selected Drugs
- New Hepatitis C Combination Agents
- Ombitasvir PK Fact Sheet Produced March 2016 Page 1 of 2 for Personal Use Only
- AHFS Pharmacologic-Therapeutic Classification System
- Study Protocol and Statistical Analysis Plan
- Remdesivir from Wikipedia, the Free Encyclopedia
- Viekira Pak (Ombitasvir, Paritaprevir and Ritonavir Tablets Co-Packaged
- Hepatitis C – Viekira Pak™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets [Co-Packaged])
- Ombitasvir-Paritaprevir-Ritonavir (Technivie)
- Viekira Paktm)
- October 2016
- Hepatitis C Sovaldi and Daklinza
- Attachment A)
- OMBITASVIR, PARITAPREVIR/RITONAVIR Co‐Formulated Tablet with Or Without DASABUVIR
- Descripción De Principios Activos
- Drugs Limited to Specific Pharmacies | Kaiser Permanente Washington
- Hepatitis C Medications Daklinza (Daclatasvir) Epclusa
- TECHNIVIE (Ombitasvir, Paritaprevir and Ritonavir) Tablets, for Oral Use
- Viekira Pak Criteria
- Treatment of Hepatitis C Hepatitis C (HCV)
- ESAC-Net Reporting Protocol 2018.Docx Introduction